Tehran, April 6, IRNA – Iran has worked out the first phase of producing the domestically made COVID-19 vaccines – Cov-Iran Barekat – and the vaccines are ready for mass production, an official with the knowledge of the case said on Tuesday.
Mohammad Mokhber, the head of the Executive Office of Imam's Directives (Setad), said that with successful completion of the clinical trial, Setad began the second phase of the trial in mid March which is nearing its end.
He expressed hope that Setad will receive the necessary permit to begin the third phase of clinical studies of the vaccine within the next couple of weeks.
Once the first phase of the clinical trial begins, Iran will begin vaccination by some three million doses of Cov-Iran Barekat vaccines each month, the official said.
